Atricure Inc. buy Needham & Company LLC
Start price
27.03.25
/
50%
€29.29
Target price
27.03.26
€47.37
Performance (%)
13.35%
Price
02.01.26
€33.20
Summary
This prediction is currently active. The prediction currently has a performance of 13.35%. This prediction currently runs until 27.03.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -5.143% | -5.143% |
| iShares Core DAX® | 0.869% | 2.751% |
| iShares Nasdaq 100 | -0.852% | -2.079% |
| iShares Nikkei 225® | 0.436% | -1.741% |
| iShares S&P 500 | -0.122% | -0.584% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat